Roche Applied Science has signed a co-research agreement that will enable Nugen Technologies develop a Nimblegen array application for small, degraded and compromised samples.
Designed to meet MAQC standards, it will explore input sample capabilities.
Using Nugen WT-Ovation Systems for amplification and labelling, the application is intended to yield a robust, highly sensitive, and reproducible workflow for global gene expression analysis.
Financial terms and commercialisation plans were not disclosed.
WT-Ovation Systems are based on Nugen's proprietary SPIA technology - a method for linear isothermal amplification of nucleic acids.
Its simple, high-fidelity approach to amplification overcomes the challenges of sample quality and quantity and enables analysis of limited and compromised biological samples.
